LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Rating of "Moderate Buy" from Analysts

Key Points

• LifeStance Health Group, Inc. has received a consensus rating of "Moderate Buy" from analysts, with one sell recommendation, five buy recommendations, and one strong buy.
• The average price objective set by analysts for the stock is $8.42, with recent upgrades by UBS Group and BTIG Research.
• Institutional investors own 85.50% of LifeStance Health Group’s stock, highlighting significant institutional interest and investment in the company.

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven ratings firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $8.50.

A number of research analysts have issued reports on the company. UBS Group lifted their target price on LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a research report on Friday. BTIG Research assumed coverage on shares of LifeStance Health Group in a research report on Friday, July 25th. They set a "buy" rating and a $8.00 price objective for the company. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a research report on Saturday.

LifeStance Health Group Price Performance

LFST traded up $0.51 on Wednesday, hitting $4.37. 7,388,878 shares of the stock were exchanged, compared to its average volume of 2,472,604. The firm has a market capitalization of $1.70 billion, a price-to-earnings ratio of -87.40 and a beta of 1.13. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.47 and a quick ratio of 1.47. LifeStance Health Group has a 12 month low of $3.74 and a 12 month high of $8.61. The business has a 50-day moving average of $4.77 and a two-hundred day moving average of $6.20.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.02. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.12%. The business had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. During the same period in the previous year, the business earned ($0.06) earnings per share. The company's revenue was up 10.6% on a year-over-year basis. Sell-side analysts forecast that LifeStance Health Group will post -0.18 EPS for the current fiscal year.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the transaction, the insider directly owned 113,435 shares of the company's stock, valued at approximately $673,803.90. The trade was a 12.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 3.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Choreo LLC increased its position in shares of LifeStance Health Group by 6.4% during the first quarter. Choreo LLC now owns 27,420 shares of the company's stock valued at $183,000 after acquiring an additional 1,661 shares during the last quarter. LPL Financial LLC grew its stake in LifeStance Health Group by 6.0% in the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company's stock valued at $277,000 after purchasing an additional 2,127 shares during the period. Invesco Ltd. increased its position in shares of LifeStance Health Group by 1.4% during the 1st quarter. Invesco Ltd. now owns 164,384 shares of the company's stock valued at $1,095,000 after purchasing an additional 2,238 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of LifeStance Health Group by 2.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock worth $1,023,000 after purchasing an additional 3,305 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey boosted its holdings in shares of LifeStance Health Group by 12.2% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 33,402 shares of the company's stock worth $173,000 after buying an additional 3,632 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.